Back to Search
Start Over
Kairos Pharma Announces New Department of Defense Funding for Research of ENV205
- Source :
- Business Wire. February 18, 2025
- Publication Year :
- 2025
-
Abstract
- LOS ANGELES -- Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600,000 in funding from [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.827834691